People on the Move and in the News

Michigan / Around the State / National / world


See Archived news

Michigan

Lansing - (11.20.06) The MDCH-HAPIS Training Unit today announced a new training consultant, Rachel Mroz. "Rachel joins us, bringing with her a wealth of knowledge and experience working in the HIV field, said Unit Manager Rhonda J. W. Bantsimba. Mroz has been an active member of the Michigan STD, HIV and Adolescents Networking Committee for many years. For the past year she has worked with the Parent Action for Healthy Kids as a Talk Early, Talk Ofter Workshop Facilitator. Previously Mroz was a prevention counselor at the Taylor Teen Health Center and a Prevention Case Manager at the Teen Pregnancy Prevention Project. She begins her new position today and will be based in Detroit at the DHWDC Cadillac Place office.

HAPIS is only filling this one position, where two trainers have moved on in recent months. Ann Miceli has returned to her passion of foreign aid work in Africa and is currently working in Malawi. Dee Hurlbert has returned to school for a teaching degree.

 

National


Former Head of Global AIDS Program Resigns in Sex Scandal
After his name surfaced in an investigation into an alleged Washington, D.C., area prostitution ring, Randall Tobias, the former U.S. Global AIDS Coordinator appointed by President George W. Bush, resigned in late April from his new post in the U.S. Department of State. Tobias, a married father of four, was a staunch proponent of abstinence-only education and was responsible for enforcing a Bush administration policy to withhold funding from countries unless they signed a pledge against prostitution. In an interview, Tobias acknowledged using the D.C.-area escort service, but insisted he only did so "to have gals come over to the condo to give me a massage." What's New at The Body, May 9, 2007

 

Five Named to NIAID Advisory Council

NIH News (3/14/07)
The National Institute of Allergy and Infectious Diseases (NIAID) today announced the appointment of five new members to the National Advisory Allergy and Infectious Diseases Council, its principal advisory body. NIAID is part of National Institutes of Health (NIH), an agency within the Department of Health and Human Services.

The council provides recommendations on the conduct and support of research, including training young scientists and disseminating health information derived from NIAID research. It embodies a diverse perspective on science, health and the human impact of disease. The council is composed of physicians, scientists and representatives of the public who contribute their time and expertise for a four-year term.

The new council members are Robert Brooks, M.D., of the Florida State University College of Medicine; Satya Dandekar, Ph.D., from the University of California, Davis; Sharon C. Kiely, M.D., M.P.H., of Allegheny General Hospital in Pittsburgh and Drexel University School of Medicine; Marc E. Rothenberg, M.D., Ph.D., from the Cincinnati Children’s Hospital Medical Center; and David S. Wilkes, M.D., of the Indiana University School of Medicine.


Satya Dandekar, Ph.D., is professor and chair, Department of Internal Medicine, University of California, Davis. Her expertise and research interests are in the areas of HIV/AIDS. She has participated in the review of grant applications and program projects for several NIH committees and has been a scientific reviewer for numerous journals and boards. She also has been invited to lecture on clinical infectious diseases for professional organizations.

Sharon C. Kiely, M.D., M.P.H., is medical director for quality and patient safety at Allegheny General Hospital in Pittsburgh and associate professor of medicine at Drexel University School of Medicine in Philadelphia. She has served on the United Network for Organ Sharing board of directors as well as the HHS Secretary’s Advisory Committee on Xenotransplantation. She is a specialist in internal medicine and has focused her clinical, research and volunteer efforts on juvenile diabetes, medical education and care to underserved populations, including those with HIV/AIDS.


NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.

The National Institutes of Health (NIH)--The Nation's Medical Research Agency--includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

 

International Moves

Patricia Pérez, an activist from Argentina who was diagnosed HIV-positive in 1986, has been nominated for the 2007 Nobel Peace Prize for her activism on behalf of women living with the AIDS virus. http://www.ipsnews.net/news.asp?idnews=37705

New Global Fund Director
[Apr 23, 2007]
Michel Kazatchkine, France's former global ambassador for HIV/AIDS and communicable diseases, on Monday will take over as the new executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria, the Boston Globe reports (Donnelly, Boston Globe, 4/22). The Global Fund in February announced that the organization's board had selected Kazatchkine to replace former Executive Director Richard Feachem, whose contract ended in March (Kaiser Daily HIV/AIDS Report, 2/9). As the Global Fund executive director, Kazatchkine will lead a financing organization that has committed $7.1 billion over five years, including $1.9 billion from the U.S., to 136 countries. (Boston Globe, 4/22).

"China's Chan Elected Head of UN Health Agency"
Agence France Presse (11.09.06):: Patrick Baert

On Thursday, the World Health Organization's World Health Assembly of member nations overwhelmingly voted to approve Dr. Margaret Chan as WHO's next director-general, the assembly's President Ivo Garrido announced. Garrido, who is also Mozambique's Health Minister, said Chan's tenure will be from Jan. 4, 2007 to June 30, 2012. Her predecessor, South Korean Lee Jong Wook, died suddenly in May. Since 2003, Chan, 59, has helped WHO deal with SARS and bird flu and became director-general for communicable diseases. Chan's new portfolio will include ongoing efforts to prevent pandemic influenza; the deepening HIV/AIDS pandemic hitting poor countries; the growing drug resistance of diseases such as TB and malaria; chronic diseases engulfing emerging nations; and the lack of primary care. The medical charity Doctors Without Borders called on Chan to renew efforts to increase access to affordable, effective drugs for millions of people in poor countries affected by infectious diseases including HIV.

 

Return to the top of the page / Return to the Home page/ Go to the Site Map (TOC) page / Search this site / If you have comments or questions about the site, please send e-mail to info@mihivnews.com